405 related articles for article (PubMed ID: 30286483)
1. The Effect of Magnesium and Vitamin E Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Jamilian M; Sabzevar NK; Asemi Z
Horm Metab Res; 2019 Feb; 51(2):100-105. PubMed ID: 30286483
[TBL] [Abstract][Full Text] [Related]
2. A Trial on The Effects of Magnesium-Zinc-Calcium-Vitamin D Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome.
Jamilian M; Maktabi M; Asemi Z
Arch Iran Med; 2017 Oct; 20(10):640-645. PubMed ID: 29137465
[TBL] [Abstract][Full Text] [Related]
3. The Influences of Chromium Supplementation on Glycemic Control, Markers of Cardio-Metabolic Risk, and Oxidative Stress in Infertile Polycystic ovary Syndrome Women Candidate for In vitro Fertilization: a Randomized, Double-Blind, Placebo-Controlled Trial.
Jamilian M; Zadeh Modarres S; Amiri Siavashani M; Karimi M; Mafi A; Ostadmohammadi V; Asemi Z
Biol Trace Elem Res; 2018 Sep; 185(1):48-55. PubMed ID: 29307112
[TBL] [Abstract][Full Text] [Related]
4. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
[TBL] [Abstract][Full Text] [Related]
5. Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
Foroozanfard F; Jamilian M; Jafari Z; Khassaf A; Hosseini A; Khorammian H; Asemi Z
Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):215-20. PubMed ID: 25868059
[TBL] [Abstract][Full Text] [Related]
6. Magnesium-zinc-calcium-vitamin D co-supplementation improves glycemic control and markers of cardiometabolic risk in gestational diabetes: a randomized, double-blind, placebo-controlled trial.
Karamali M; Bahramimoghadam S; Sharifzadeh F; Asemi Z
Appl Physiol Nutr Metab; 2018 Jun; 43(6):565-570. PubMed ID: 29316405
[TBL] [Abstract][Full Text] [Related]
7. The Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Indices of Insulin Resistance and Hormonal Parameters in Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Ebrahimi FA; Samimi M; Foroozanfard F; Jamilian M; Akbari H; Rahmani E; Ahmadi S; Taghizadeh M; Memarzadeh MR; Asemi Z
Exp Clin Endocrinol Diabetes; 2017 Jun; 125(6):353-359. PubMed ID: 28407657
[TBL] [Abstract][Full Text] [Related]
8. A randomized-controlled clinical trial investigating the effect of omega-3 fatty acids and vitamin E co-supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes.
Taghizadeh M; Jamilian M; Mazloomi M; Sanami M; Asemi Z
J Clin Lipidol; 2016; 10(2):386-93. PubMed ID: 27055970
[TBL] [Abstract][Full Text] [Related]
9. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z
Exp Clin Endocrinol Diabetes; 2018 Apr; 126(4):222-228. PubMed ID: 29117618
[TBL] [Abstract][Full Text] [Related]
10. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization.
Dastorani M; Aghadavod E; Mirhosseini N; Foroozanfard F; Zadeh Modarres S; Amiri Siavashani M; Asemi Z
Reprod Biol Endocrinol; 2018 Oct; 16(1):94. PubMed ID: 30286768
[TBL] [Abstract][Full Text] [Related]
11. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome.
Rahmani E; Samimi M; Ebrahimi FA; Foroozanfard F; Ahmadi S; Rahimi M; Jamilian M; Aghadavod E; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z
Mol Cell Endocrinol; 2017 Jan; 439():247-255. PubMed ID: 27619403
[TBL] [Abstract][Full Text] [Related]
12. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.
Javed Z; Papageorgiou M; Deshmukh H; Kilpatrick ES; Mann V; Corless L; Abouda G; Rigby AS; Atkin SL; Sathyapalan T
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30658483
[TBL] [Abstract][Full Text] [Related]
13. The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Maktabi M; Chamani M; Asemi Z
Horm Metab Res; 2017 Jul; 49(7):493-498. PubMed ID: 28679140
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Magnesium and Vitamin E Co-Supplementation on Hormonal Status and Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome.
Shokrpour M; Asemi Z
Biol Trace Elem Res; 2019 Sep; 191(1):54-60. PubMed ID: 30565017
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Response to Omega-3 Fatty Acids and Vitamin E Co-Supplementation in Patients with Fibrocystic Breast Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.
Mirhashemi SM; Sahmani M; Salehi B; Zavar Reza J; Taghizadeh M; Moussavi N; Badehnoosh B; Asemi Z
Arch Iran Med; 2017 Aug; 20(8):466-473. PubMed ID: 28846009
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Magnesium and Zinc Co-Supplementation on Biomarkers of Inflammation and Oxidative Stress, and Gene Expression Related to Inflammation in Polycystic Ovary Syndrome: a Randomized Controlled Clinical Trial.
Afshar Ebrahimi F; Foroozanfard F; Aghadavod E; Bahmani F; Asemi Z
Biol Trace Elem Res; 2018 Aug; 184(2):300-307. PubMed ID: 29127547
[TBL] [Abstract][Full Text] [Related]
17. Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
Jamilian M; Razavi M; Fakhrie Kashan Z; Ghandi Y; Bagherian T; Asemi Z
Clin Endocrinol (Oxf); 2015 Jun; 82(6):885-91. PubMed ID: 25510442
[TBL] [Abstract][Full Text] [Related]
18. Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Foroozanfard F; Talebi M; Samimi M; Mehrabi S; Badehnoosh B; Jamilian M; Maktabi M; Asemi Z
Horm Metab Res; 2017 Aug; 49(8):612-617. PubMed ID: 28679142
[TBL] [Abstract][Full Text] [Related]
19. Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Jamilian M; Asemi Z
Ann Nutr Metab; 2015; 67(1):42-8. PubMed ID: 26279073
[TBL] [Abstract][Full Text] [Related]
20. The effects of magnesium and vitamin E co-supplementation on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
Afzali H; Jafari Kashi AH; Momen-Heravi M; Razzaghi R; Amirani E; Bahmani F; Gilasi HR; Asemi Z
Wound Repair Regen; 2019 May; 27(3):277-284. PubMed ID: 30693609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
